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ABSTRACT
Background: Over the last 20 years, a number of instruments developed for the assessment of health-related
quality of life (HRQL) in dementia have been introduced. The aim of this review is to synthesize evidence
from published reviews on HRQL measures in dementia and any new literature in order to identify dementia
specific HRQL instruments, the domains they measure, and their operationalization.
Methods: An electronic search of PsycINFO and PubMed was conducted, from inception to December 2011
using a combination of key words that included quality of life and dementia.
Results: Fifteen dementia-specific HRQL instruments were identified. Instruments varied depending on their
country of development/validation, dementia severity, data collection method, operationalization of HRQL
in dementia, psychometric properties, and the scoring. The most common domains assessed include mood,
self-esteem, social interaction, and enjoyment of activities.
Conclusions: A number of HRQL instruments for dementia are available. The suitability of the scales for
different contexts is discussed. Many studies do not specifically set out to measure dementia-specific HRQL
but do include related items. Determining how best to operationalize the many HRQL domains will be helpful
for mapping measures of HRQL in such studies maximizing the value of existing resources.
Keywords: systematic review, psychometric properties, dimensions, operationalization, scales, mood
Introduction
Dementia is one of the most common disorders
of old age (Ferri et al., 2005; Marengoni et al.,
2008) and a leading cause of mortality and
disability in high-income countries (Lopez et al.,
2006). Medications temporarily reduce symptoms
for some, but without modifying the underlying
course of the disorder, which is related to many
underlying causes. Narrow assessment of cognition
and functional ability is insufficient for clinical
decision-making and policy development as they
only reflect a part of the impact of dementia
(Whitehouse, 2000). Treatment is increasingly
focused on improving or maintaining optimal
quality of life (QoL; Ettema et al., 2005a) as
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this has become a key outcome for evaluating the
effectiveness of dementia interventions (Small et al.,
1997;Whitehouse, 2000;Moniz-Cook et al., 2008).
Health-related quality of life (HRQL) can be
defined as the individual’s perception of the impact
of a health condition on everyday life (Bullinger
et al., 1993). It differs from the concept of quality of
life in that HRQL includes only aspects of quality
of life that are affected by a health condition.
Despite the lack of agreement of what domains
constitute HRQL, most authors appear to agree
upon the multidimensional and subjective nature of
the concept and that the assessment should include
measurement of positive and negative dimensions
(Lawton, 1994; The WHOQOL Group, 1995;
Brown et al., 2004; Ready, 2011).
Multiple measures have been developed spe-
cifically for assessing HRQL in patients with
Alzheimer’s disease or related dementias.
These instruments can be either generic HRQL
questionnaires used in dementia populations such
as the World Health Organization Quality of
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Life Assessment (WHOQOL) or Schedule for the
Evaluation of Individual Quality of Life (SEIQoL;
The WHOQOL Group, 1998; Schölzel-Dorenbos,
2000), dimension specific scales such as the
Progressive deteriorations Scale (PDS) (DeJong
et al., 1989) or dementia specific such as the
Quality of Life in Alzheimer’s Disease (QoL-AD)
or the DEMQOL (Logsdon et al., 1999; Smith
et al., 2005a). A number of studies have reviewed
the different instruments used to measure HRQL
in dementia (e.g. Ready and Ott, 2003; Ettema
et al., 2005a). However, no attempt has been
made as yet to synthesize the findings across the
different reviews. Although one study has discussed
the appropriateness of different scales (Schozel-
Dorenbos et al., 2007), this did not use a systematic
methodology. No review has assessed the features of
the different scales in detail in order to assess their
suitability in different contexts.
The aim of this paper is to synthesize the evidence
from reviews on HRQL instruments for dementia
and any new literature to bring together and provide
an update on dementia-specific HRQL measures
providing details of their features including: number
of items, scoring, data-collection method, severity
in which the instrument may be administered,
domains, time frame, countries where the scales
were developed or validated, and measures of
reliability and validity. The suitability of the scales
in different contexts is discussed. Conceptualization
and operationalization of dementia-specific HRQL
domains by each dementia-specific instrument are
analyzed and compared for consistency.
Methods
In order to synthesize the evidence from reviews
on HRQL instruments in dementia, J. Perales
conducted an electronic search in PubMed from
inception toDecember 2011 using a combination of
key words that included quality of life and dementia
as major topic Mesh terms and specifying reviews
as type of publication. The publications could be in
either English or Spanish language.
In order to identify previous and new literature,
a second electronic search was conducted of Psy-
cINFO and PubMed, from inception to December
2011 using a combination of words that included
quality of life and dementia as major topic Mesh
terms or keywords. The criteria for inclusion were:
(i) papers, abstracts or scale manuals that were pub-
lished in English or Spanish language on dementia-
specific HRQL measures developed for use with
on patients with AD or mixed dementia; and (ii)
reporting on the development, description of the
dimensions, and psychometric properties of an
instrument. In order to report country of validation
of the scales, those papers with abstracts in English
irrespective of the rest of the text were also included.
Generic, domain-specific QoL measures such as
those measuring only activities of daily living (De-
Jong et al., 1989) and Parkinson’s disease-specific
HRQLmeasures are beyond the scope of this review
and were excluded. This review excluded consider-
ations of caregiver quality of life except where this
was related to measures of patient HRQL.
Literature selection was undertaken in two
phases. In phase 1, titles and abstracts of all papers
were independently reviewed (J. Perales and T.D.
Cosco) to exclude non-related publications. Full-
text papers accepted in phase 1 were reviewed in
order to extract the appropriate information (phase
2). In case of discrepancy, if no agreement was
met by both readers after discussion, a third author
would decide (B.C.M. Stephan). In order to rate
the psychometric quality assessment of each of the
instruments, standardized criteria was used. These
criteria are shown in Table 1.
Results
Reviews identified (literature search 1)
Of the 271 papers identified in the first literature
search, eight were reviews on HRQL instruments
in dementia (Salek et al., 1998; Walker et al.,
1998; Ready and Ott, 2003; Ettema et al., 2005a;
Smith et al., 2005a; Lucas-Carrasco, 2007; Schozel-
Dorenbos et al., 2007; Ready, 2011). Only four
(Salek et al., 1998; Walker et al., 1998; Ready and
Ott, 2003; Ettema et al., 2005a) used a systematic
approach. Table 2 shows the dementia-specific
HRQL instruments included in each of the eight
reviews identified. Although the number of reviews
increases by year of publication, there are some
inconsistencies in the instruments included. The
reviews highlight the wide variation in instruments,
their items, and methods of scoring, psychometric
properties, data collection method, severity of
dementia, and the populations used to assess
validity and reliability.
Instruments identified (literature search 2)
Figure 1 shows the selection process for the
review on dementia-specific HRQL. In total, 848
papers were identified. After the title-abstract
screen, 76 papers remained. Based on the full-
text search, 68 publications covering 15 different
dementia-specific HRQL scales were identified and
included in this review. The dementia-specific
HRQL measures reviewed included: the Alzheimer
Disease Related Quality of Life (ADRQL), Bath
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Table 1. Psychometric criteria
PSYCHOMETRIC
PROPERTY DEFINITION/TEST CRITERIA FOR ACCEPTABILITY
.....................................................................................................................................................................................................................................................................................................................
Item analysis/reduction Identification of items for possible elimination
owing to weak psychometric performance;
assessed on the basis of (1) unrotated
principal component factor analysis to
determine whether all items are measuring a
single factor and (2) item analyses for all items
Principal component factor analysis:
All items should load on the first unrotated
factor >0.30
Item analyses (applied to all items):
Missing data <5%
No item redundancy (inter-item
correlations ≤0.75)
Item-total correlations >0.25
Maximum endorsement frequencies ≤80%
(i.e. the proportion of respondents who
endorse each response category),
including floor/ceiling effects <80% (i.e.
response categories with high
endorsement rates at the bottom/top
ends of the scale, respectively) Aggregate
adjacent endorsement frequencies ≥10%
Acceptability The quality of data; assessed by completeness of
data and score distributions
Missing data for summary scores <5%
Even distribution of endorsement
frequencies across response categories
Floor ceiling effects for summary scores
<10%
Reliability
Internal consistency The extent to which items comprising a scale
measure the same construct (e.g. homogeneity
of the scale); assessed by Cronbach’s α and
item-total correlations
Cronbach’s α for summary scores ≥0.70
Item-total correlations ≥0.20
Test–retest The stability of a measuring instrument;
assessed by administering the instrument to
respondents on two different occasions and
examining the correlation between test and
retest scores
Test–retest reliability correlations for
summary scores ≥0.70
Inter-rater Agreement between independent
raters/observers; assessed by ICCs
ICC ≥0.70
Parallel (alternative)
forms
Agreement between two or more
parallel/alternative forms or different versions
of the same measure (e.g. form A/B,
short/long form) that indicates that they can
be used interchangeably; assessed on the basis
of correlations between parallel/ alternative
forms of a measure
High correlations between
parallel/alternative forms of the measure
(e.g. between long and short form)
Validity
Content The extent to which the content of a scale is
representative of the conceptual domain it is
intended to cover; assessed qualitatively
during the questionnaire development stage
through pretesting with patients, expert
opinion, and literature review
Qualitative evidence from pretesting with
patients, expert opinion, and literature
review that items in the scale are
representative of the construct being
measured
Criterion related
Concurrent Evidence that the scale predicts a gold-standard
criterion that is measured at the same time;
assessed on the basis of correlations between
the scale and the criterion measure.
High correlation between the scale and the
criterion measure
Predictive Evidence that the scale predicts a gold-standard
criterion that is measured in the future;
assessed on the basis of correlations between
the scale and the criterion measure.
High correlation between the scale and the
criterion measure
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Table 1. Continued.
PSYCHOMETRIC
PROPERTY DEFINITION/TEST CRITERIA FOR ACCEPTABILITY
.....................................................................................................................................................................................................................................................................................................................
Construct validity
Within-scale analyses Evidence that a single entity (construct) is being
measured and that items can be combined to
form a summary score; assessed on the basis
of evidence of good internal consistency and
correlations between scale scores (which
purport to measure related aspects of the
construct)
Internal consistency (Cronbach’s α) ≥0.70
Moderate to high correlations between
scale scores
Analyses against
external criteria
Convergent Evidence that the scale is correlated with other
measures of the same or similar constructs;
assessed on the basis of correlations between
the measure and other similar measures
Correlations are expected to vary according
to the degree of similarity between the
constructs that are being measured by
each instrument. Specific hypotheses are
formulated and predictions tested on the
basis of correlations
Discriminant Evidence that the scale is not correlated with
measures of different constructs; assessed on
the basis of correlations with measures of
different constructs
Low correlations between the instrument
and measures of different constructs
Known groups
differences
The ability of a scale to differentiate known
groups; assessed by comparing scores for
subgroups who are expected to differ on the
construct being measured
Significant differences between known
groups or difference of expected
magnitude
Responsiveness The ability of a scale to detect clinically
important change over time; assessed by
comparing scores before and after an
intervention of known efficacy (on the basis of
various methods including t tests, effect sizes,
standardized response means, or
responsiveness statistics)
Significant differences between known
groups or difference of expected
magnitude
Adapted from Smith et al. (2005a).
Assessment of Subjective Quality of Life in
Dementia (BASQUID), Cornell-Brown Scale for
Quality of Life in Dementia (CBS), Dementia
Care Mapping (DCM), Dementia Quality of
Life Instrument (D-QoL), DEMQOL, Patient
Activity Scale-AD plus the Modified Apparent
Emotion Scale (PES-AD + AES), Quality of
Life in Late-stage Dementia Scale (QUALID),
QoL-AD, Quality of Life Assessment Schedule
(QOLAS), Quality of Life for Dementia (QoL-D),
QUALIDEM, Quality of Life for Older People
Experiencing Dementia (QLDJ), Vienna List, and
the Community Dementia Quality of Life Profile.
As shown in Table 2, none of the reviews
included the QLDJ or identified all the instruments.
Table 3 shows the publications reviewed for each of
the instruments. Some publications have assessed
the psychometric properties of more than one
instrument at a time (Edelman et al., 2005; Sloane
et al., 2005; Smith et al., 2005a).
Potentially relevant studies 
identified and screened for 
retrieval (n = 848) 
Studies excluded 
after screening 
(n = 772) 
Studies included in review 
(n = 68) 
Potentially appropriate 
studies to be included in the 
review (n = 76) 
Studies 
excluded 
after 
evaluation 
(n = 20) 
Studies retrieved for more 
detailed evaluation (n = 56) Studies 
included 
from 
references 
(n = 12) 
Figure 1. Flow chart of paper selection for the review on dementia-
speciﬁc health-related quality-of-life instruments.
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Table 2. Dementia-speciﬁc HRQL instruments included in each of the eight reviews identiﬁed in our search
SCALE/REVIEW
WALKER
AND
SALEK
(1998)a,b
READY
(2003)c
ETTEMA
(2005a)d
SMITH
(2005a)e
LUCAS-
CARRASCO
(2007) f
SCHOZEL-
DORENBOS
(2007)g
READY
(2011)h
........................................................................................................................................................................................................................................................................................................................
D-QoL × × × × × × ×
QoL-AD × × × × × × ×
DCM × × × × ×
CBS × × × × ×
QOLAS × × × ×
ADRQL × × × × × ×
QUALID × × ×
QoL-D × × ×
DEMQOL × × × ×
QUALIDEM × ×
BASQID ×
QLDJ
PES-AD+AES × × × × ×
CDQLP × ×
Vienna List ×
aSalek et al. (1998); bWalker et al. (1998); cReady and Ott (2003); dEttema et al. (2005a); eSmith et al. (2005a); fLucas-Carrasco (2007);
gSchozel-Dorenbos et al. (2007); hReady (2011).
ADRQL: Alzheimer Disease Related Quality of Life; BASQID: The Bath Assessment of Subjective Quality of Life in Dementia; CDQLP:
The Community Dementia Quality of Life Profile; CBS: Cornell-Brown Scale for Quality of Life in Dementia; DCM: Dementia Care
Mapping; D-QoL: Dementia Quality of Life Instrument; QLDJ: Quality of Life for Older People Experiencing Dementia; QoL-AD:
Quality of Life in Alzheimer’s Disease; QoL-D: Quality of Life for Dementia; QOLAS: Quality of Life Assessment Schedule; QUALID:
Quality of Life in Late-Stage Dementia Scale.
Instrument features
Table 4 summarizes the characteristics of the
original version of each of the 15 different
instruments and reports the existence of validations
in other countries. There are two instruments
where only self-report is possible, six proxy-report-
only measures, four measures that include both
self and proxy ratings, and three observer-rated
instruments. The number of items varies between
10 in the QOLAS and 47 in the ADRQL. Three
scales can obtain both total and subscale scores
whereas six can only obtain subscale scores and six
only total scores. Response scales vary from being
binary to six-point Likert scales. Most response
scales of observation-rated measures or those rated
only by proxies ask about frequency of a certain
behavior, whereas the other types of instruments
vary between quality, how much of a problem,
satisfaction, or worry of a trait. The psychometric
properties of self-report only measures (Brod et al.,
1999; Trigg et al., 2007a) have been tested in
patients with mild-moderate dementia severity as
have all measures using both types of report except
for DEMQOL-proxy and QoL-AD. Two proxy-
report only (Salek et al., 1997; Black et al., 1999)
and two observer-rated instruments (Fossey et al.,
2002; Ettema and Lange, 2007) have tested their
psychometric properties in patients of all dementia
severity whereas the psychometric properties of the
rest have been tested in patients with moderate-
severe dementia severity. The time frame of the
questions is usually either in the present or in
the previous week/two weeks. The number of
dimensions ranges from two in the case of the
DCM and PES-AD+AES to 13 in the QoL-AD.
Most instruments have been developed in the USA
(6) (Albert et al., 1996; Black et al., 1999; Brod
et al., 1999; Logsdon et al., 1999; Weiner et al.,
2000; Ready et al., 2002) or the UK (5) (Salek
et al., 1997; Selai et al., 2001a; Fossey et al., 2002;
Smith et al., 2005a; Trigg et al., 2007b). However,
other instruments have also been developed in Japan
(2) (Terada et al., 2002; Yamamoto-Mitani et al.,
2002), theNetherlands (1) (Ettema et al., 2007) and
Austria (1) (Porzsolt et al., 2004). Five instruments
(Brod et al., 1999; Logsdon et al., 1999; Weiner
et al., 2000; Fossey et al., 2002; Smith et al., 2005a)
have been validated in other countries. None of the
samples used to assess the psychometric properties
of each of the instruments were population based.
Conceptualization and operationalization
The most common domains across different
dementia-specific HRQL instruments are mood,
social interaction, enjoyment of activities/sense
of aesthetics, and self-esteem/self-concept. Other
common domains are cognition, activities, health,
living conditions, and feelings of usefulness.
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Table 3. Primary and secondary papers on dementia-speciﬁc HRQL measures identiﬁed in our search
INSTRUMENT
PRIMARY PAPERS
(DEVELOPMENT)
SECONDARY PAPERS
(MODIFICATIONS
AND VALIDATIONS
IN OTHER
COUNTRIES)
...................................................................................................................................................................................................................................................................................................................
Alzheimer Disease Related Quality of Life (ADRQL) 1, 2 3, 4, 5, 6
Bath Assessment of Subjective Quality of Life in Dementia (BASQID) 7, 8
Cornell-Brown Scale for Quality of Life in Dementia (CBS) 9
Community Dementia Quality of Life Profile (CDQLP) 10–14
Dementia Care Mapping (DCM) 15 5, 1618
DEMQOL 19, 20 21, 22
Dementia Quality of Life Instrument (D-QoL) 23 5, 6, 19, 24–32, 33
Patient Activity Scale-AD plus the Modified Apparent Emotion Scale
(PES-AD +AES)
34, 35 5
Quality of Life for Older People Experiencing Dementia (QLDJ) 36, 37
Quality of Life-Alzheimer’s Disease (QoL-AD) 38, 39 6, 19, 40–56
Quality of Life Assessment Schedule (QOLAS) 57
Quality of Life for Dementia (QoL-D) 58
Quality of Life in Late-stage Dementia Scale (QUALID) 59 60–64
QUALIDEM 65–67
Vienna List 68
References. 1: Rabins et al. (1999); 2: Black et al. (1999); 3: Kasper et al. (2009); 4: Black et al. (2009); 5: Sloane et al. (2005);
6: Edelman et al. (2005); 7: Trigg et al. (2007a); 8: Trigg et al. (2007b); 9: Ready et al. (2002); 10: Salek et al. (1999); 11: Salek et al.
(1996); 12: Walker et al. (2001a); 13: Walker et al. (2001b); 14: Salek et al. (1997); 15: Fossey et al. (2002); 16: Sloane et al. (2007); 17:
Suzuki et al. (2008); 18: Brooker and Surr (2006); 19: Smith et al. (2005a); 20: Smith et al. (2005b); 21: Smith et al. (2007); 22:
Lucas-Carrasco et al. (2010); 23: Brod et al. (1999); 24: Adler and Resnick (2010); 25: Lucas-Carrasco et al. (2011); 26: Chiu et al.
(2008); 27: Chiu et al. (2010); 28: Karim et al. (2008); 29: Ready et al. (2007); 30: Suzuki et al. (2005); 31: Suzuki et al. (2006); 32:
Bosboom and Jonkers (2001); 33: Porzsolt et al. (2004); 34: Albert et al. (1996); 35: Albert et al. (2001); 36: Yamamoto-Mitani et al.
(2002); 37: Yamamoto-Mitani et al. (2004); 38: Logsdon et al. (1999); 39: Logsdon et al. (2002); 40: León-Salas et al. (2011); 41:
Chan et al. (2011); 42: Fuh and Wang (2006); 43: Hoe et al. (2005); 44: Lin Kiat Yap et al. (2008); 45: Matsui et al. (2006); 46:
Hao-ying and Guo-dong (2005); 47: Rosas-Carrasco et al. (2010); 48: Shin (2006); 49: Novelli et al. (2010); 50: Novelli et al. (2005);
51: Patterson et al. (2006); 52: Revell et al. (2009); 53: Selai et al. (2001b); 54: Thorgrimsen et al. (2003); 55: Wolak et al. (2009); 56:
Merchant et al. (2004); 57: Selai et al. (2001a); 58: Terada et al. (2002); 59: Weiner et al. (2000); 60: Barca et al. (2011); 61: Falk et al.
(2007); 62: Garre-Olmo et al. (2010); 63: Martin-Cook et al. (2005); 64: Schalkwijk et al. (2009); 65: Ettema et al. (2007); 66: Bouman
et al. (2011); 67: Ettema and Lange (2007); 68: Porzsolt et al. (2004).
Domains are operationalized differently across
instruments. Most domains are operationalized
either through the patient or proxy’s perception
of the different domains or through the rating of
observational behaviors or contexts.
Most instruments measure mood as positive
and negative affect although two exceptions are
the QoL-AD, which asks for mood in general,
and the QOLAS, which needs to be given
two examples within the mood domain by the
respondent. Common items on positive affect are
cheerfulness, happiness, contentment, and calm.
The most common items indicating negative effect
are sadness, anger, worry, and anxiety. Proxy
and observation-based instruments usually measure
either observational indicators of patient’s mood
(such as crying) or proxy’s perception of the
patient’s mood. A similar trend can be observed in
other dimensions. For example, social interaction
has been assessed as the perception by the patient
or the proxy of the patient’s quality of interactions
such as worries about not having enough company,
satisfaction or problems with social relationships,
or through observation-based ratings such as
frequency of visiting friends, talking or seeking
or rejecting contact with people. Enjoyment of
activities has been measured through perception,
satisfaction, or worry about enjoyment of different
activities, or observation-based assessments such
as voluntarily participation in activities and talking
about work or activities. A special case is the
domain sense of aesthetics, which has been defined
as the ability to enjoy sensory stimuli. Items on
self-esteem involve perceptions of usefulness, self-
confidence, and satisfaction with oneself. Observer-
based ratings consist usually in noticing that patients
mention they are worthless, hopeless, or useless.
Some questionnaires such as the ADRQL measure
awareness of self with items such as responding to
one’s own name. Some instruments also include
activities of daily living in their assessment of
HRQL. These items have been measured as
the patient or proxy’s perception of the ability
to do chores such as walking, cooking, eating,
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Table 4. Dementia-speciﬁc instruments reviewed and their characteristics
MEASURE
NO. OF
ITEMS SCORING RESPONSE SCALE SEVERITY TIME FRAME DIMENSIONS
VALIDATED
IN
POPULATION
STUDIES
COUNTRY OF
VALIDATION
............................................................................................................................................................................................................................................................................................................................................................................................................................................................
Self-rated only
BASQID 14 Total and
subscales
5 point (not at all
satisfied–extremely
satisfied) and (not
at all–a great deal
Mild–moderate Present Life satisfaction, feelings of
positive QoL
No UK (original)
D-QoL 29 Subscales 5 point (never–very
often) and (not at
all–very)
Mild–moderate Recently Positive affect, negative
affect, feelings of
belonging, self-esteem,
sense of aesthetics
No USA (original), China,
Japan, Spain, UK,
Netherlands
Patient and
proxy rated
CBS 19 Total 5 point (negative
end–positive end)
Mild–moderate Previous week Positive affect, negative
affect, satisfactions,
physical complaints
No USA (original)
DEMQOL 28 (p),
31 (c)
Total 4 point (a lot–not at
all)
Mild–moderate
(p) all stages
(c)
Previous week Daily activities, health and
well-being, cognitive
functioning, social
relationships, self-concept
No UK (original), Spain
QoL-AD 12 Total 4 point
(poor–excellent)
All stages Present Physical health, energy,
mood, living situation,
memory, family,
marriage, friends, self as a
whole, ability to do chores
around the house, ability
to do things for fun,
money, QoL as a whole
No USA (original), China
(Cantonese and
Mandarin), Taiwan,
Spain, Japan, Brazil,
Korea, France, (and
French Switzerland),
Mexico, UK
QOLAS 10 Total 6 point (no
problem–it could
not be worse)
Mild–moderate Present Physical, psychological,
social/family, usual
activities, cognitive
functioning
No UK (original)
Proxy-rated
only
ADRQL 47 Total and
subscales
Dichotomous
(agree/disagree)
All stages Previous 2 weeks Social interaction,
awareness of self, feelings
and mood, enjoyment of
activities, response to
surroundings
No USA (original)
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Table 4. Continued.
MEASURE
NO. OF
ITEMS SCORING RESPONSE SCALE SEVERITY TIME FRAME DIMENSIONS
VALIDATED
IN
POPULATION
STUDIES
COUNTRY OF
VALIDATION
............................................................................................................................................................................................................................................................................................................................................................................................................................................................
CDQLP 33 Total 4 point (not at
all–always)
All stages Previous 2 weeks Thinking and behavior,
family and social life,
physical activities,
other aspects of daily
living
No UK (original)
PES-AD+
AES
21 Subscales Activity: 3 point
(frequently–
never), affect: 5
point (never– ≥3×
day)
Mild Affect: previous
2 weeks,
activity:
previous week
Activity, affect No USA (original)
QLDJ 24 Total and
subscales
4 point (not at all
applicable, very
much applicable)
Moderate–
severe
Previous 2 weeks Interacting with
surroundings,
expressing self,
experiencing minimum
negative behaviors
No Japan (original)
QoL-D 31 Subscales 4 point
(none–frequent)
Moderate–
severe
Not specified Positive affect, negative
affect and actions,
ability of
communication,
restlessness,
attachment with
others, spontaneity and
activity
No Japan (original)
QUALID 11 Total 5 point (different
options of
frequency)
Moderate–
severe
Previous week Affect, comfort, and
engagement with
activities
No USA (original), Sweden,
Spain
Observational
assessment
DCM 26 Subscales Well-being: 6 point
(extreme
ill-being–extreme
well-being)
All stages Every 5 minutes
for 6 hours
Well-being, activity No UK (original), Japan
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and shopping or how much problem or worry
these activities involve. The same applies to the
assessment of cognitive functioning. Other domains
that have not been included so often include self-
rated health, financial, and living context.
Psychometric properties
Table 5 shows the psychometric quality assessment
using the criteria shown inTable 1. Ten instruments
(Albert et al., 1996; Salek et al., 1997; Black et al.,
1999; Logsdon et al., 1999; Weiner et al., 2000;
Selai et al., 2001a; Fossey et al., 2002; Ready
et al., 2002; Yamamoto-Mitani et al., 2002; Porzsolt
et al., 2004) either were not tested for acceptability
or did not meet the criteria. Regarding reliability,
all instruments but PES-AD+AES, DCM, and
DEMQOL-Proxy show good evidence of internal
consistency. Eight instruments (Salek et al., 1997;
Brod et al., 1999; Logsdon et al., 1999;Weiner et al.,
2000; Yamamoto-Mitani et al., 2002; Smith et al.,
2005a; Ettema et al., 2007; Trigg et al., 2007b)
showed good evidence of test–retest reliability.
Among those instruments assessed by a proxy or
an observer, six instruments assessed inter-rater
reliability, most of them showing good evidence.
Regarding validity, ten instruments showed good
evidence of content validity (Salek et al., 1997;
Black et al., 1999; Brod et al., 1999; Logsdon
et al., 1999; Selai et al., 2001a; Terada et al., 2002;
Yamamoto-Mitani et al., 2002; Smith et al., 2005a;
Ettema et al., 2007; Trigg et al., 2007b). Despite
the fact that criterion-related validity cannot be
tested due to the lack of a gold standard, two
measures (Selai et al., 2001a; Ready et al., 2002)
claim to show some evidence of it, perhaps referring
to convergent validity. Regarding analyses against
external criteria, 14 instruments (Albert et al., 1996;
Salek et al., 1997; Black et al., 1999; Brod et al.,
1999; Logsdon et al., 1999; Weiner et al., 2000;
Selai et al., 2001a; Fossey et al., 2002; Ready et al.,
2002; Terada et al., 2002; Porzsolt et al., 2004;
Smith et al., 2005a; Ettema et al., 2007; Trigg
et al., 2007b) show evidence of convergent validity
but not discriminant or known groups differences.
Six measures have shown responsiveness (D-
QoL, BASQID, QoL-AD, ADRQL, QUALID,
and DCM). Finally, the factorial structure of nine
instruments has been analyzed (Brod et al., 1999;
Salek et al., 1999; Weiner et al., 2000; Fossey et al.,
2002; Terada et al., 2002; Yamamoto-Mitani et al.,
2002; Smith et al., 2005a; Trigg et al., 2007b; Revell
et al., 2009), most of them finding subscales.
Discussion
This review synthesizes the information on
dementia specific HRQL instruments from reviews
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Table 5. Psychometric properties of the dementia-speciﬁc instruments
FACTOR OR
CRITERION- KNOWN PRINCIPAL
INTERNAL TEST– INTER-RATER CONTENT RELATED CONVERGENT DISCRIMINANT GROUPS COMPONENTS
MEASURE ACCEPTABILITY CONSISTENCY RETEST RELIABILITY VALIDITY VALIDITY VALIDITY VALIDITY DIFFERENCES RESPONSIVENESS ANALYSIS..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................
Self-rated only
BASQID ++ +++ +++ NA +++ − +++ ++ − Yes Yes
D-QoL ++ +++ +++ NA +++ − ++ − ++ − Yes
Patient and
proxy rated
CBS − +++ − NA (c)/ ++ +(p) − + ++ − − − −
DEMQOL ++ (c) (+++(p) +++ (c) (++(p) +++ NA (c)(− (p) +++ − ++ ++ − (c)( + (p) − Yes
QoL-AD − +++ +++ NA (c)/ − (p) +++ − +++ − − (c)/ +++(p) Yes Yes
QOLAS − +++ − NA (c)/ − (p) +++ + ++ − ++ − −..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................
FACTOR OR
CRITERION- KNOWN PRINCIPAL
INTERNAL TEST– INTER-RATER CONTENT RELATED CONVERGENT DISCRIMINANT GROUPS COMPONENTS
MEASURE ACCEPTABILITY CONSISTENCY RETEST RELIABILITY VALIDITY VALIDITY VALIDITY VALIDITY DIFFERENCES RESPONSIVENESS ANALYSIS..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................
Proxy rated
only
ADRQL − +++ − − +++ − +++ − − Yes −
CDQLP − +++ +++ − +++ − + − − − Yes
PES-
AD+AES
− − ++ − − − + − − Yes −
QLDJ − +++ +++ ++ +++ − − ++ + − Yes
QoL-D +++ +++ − +++ +++ − ++ − − − Yes
QUALID − +++ +++ +++ − − +++ ++ − Yes Yes
Observational
assessment
DCM − + + − − + ++ − − Yes Yes
QUALIDEM
++ +++ +++ ++ +++ − +++ +++ − − −
Vienna List − +++ − ++ + − ++ − − − −
p = patient version; c = caregiver version.
CRITERIA EXAMPLE
−No evidence or not tested. ADRQL did not assess acceptability
+Some limited evidence CDQLP only reported the p value when examining the association
between the total score and the MMSE score
++Some good evidence but some aspect do not
meet criteria or some aspects not tested/reported
DEMQOL’s acceptability: missingness is always higher than 5%
although there is no floor or ceiling effect.
+++Good evidence DEMQOL proxy’s acceptability: missingness is always lower than
5% and there are no floor or ceiling effects.
NA, not applicable Inter-rater reliability in self-rated scales
ADRQL: Alzheimer Disease-Related Quality of Life; BASQID: The Bath Assessment of Subjective Quality of Life in Dementia; CDQLP: The Community Dementia Quality of Life Profile;
CBS: Cornell-Brown Scale for Quality of Life in Dementia; DCM: Dementia Care Mapping; D-QoL: Dementia Quality of Life Instrument; QLDJ: Quality of Life for Older People Experiencing
Dementia; QoL-AD: Quality of Life in Alzheimer’s Disease; QoLAS: Quality of Life Assessment Schedule; QUALID: Quality of Life in Late-stage Dementia Scale.
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(Salek et al., 1998; Walker et al., 1998; Ready
and Ott, 2003; Ettema et al., 2005a; Smith et al.,
2005a; Lucas-Carrasco, 2007; Schozel-Dorenbos
et al., 2007; Ready, 2011) and builds on these by
gathering them all into a single study and identifying
one new measure, the QLDJ.
While this is a systematic review, we did not
include measures assessing only a specific domain
of HRQL such as the PDS (DeJong et al., 1989),
or generic HRQL scales that are not tailored to
people with dementia (Rabins et al., 1999; Silberfeld
et al., 2002). Their focus on health and function
imply that HRQL will decrease automatically with
disease progression (Ettema et al., 2005a) and some
of these lack evidence on validity or reliability
in dementia populations (Ettema et al., 2005a).
We also did not include instruments that measure
the QoL of caregivers of people with dementia
as these are outside the scope of this review.
The literature searches were conducted in English
and in Anglophone databases and, therefore,
instruments developed in non-English-speaking
countries without a translation available would
have been missed. However, regarding instrument
development and validation, we accepted any
publication as long as the abstract was in English
or Spanish.
Conceptualization and operationalization
The concept of HRQL in dementia has been
influenced by the broader concept ofQoL that refers
to “evaluation by subjective and social-normative
criteria, of the behavioral and environmental
situation of a person” (Lawton, 1994). There has
been a movement in QoL toward the measurement
of the experience of the person, including usually
perceptions or satisfactions with psychological,
physical, and social domains (Ettema et al.,
2005b). In dementia-specific HRQL instruments,
the measurement is also aimed at capturing the
experience of the person with dementia. Domains
commonly measured are mood, self-esteem, social
interaction, and enjoyment of activities. Similarly
to the general concept of QoL, normative measures
such as income or cognitive tests (different to
perception or satisfaction with such domains)
have been excluded and considered as a different
outcome (Brod et al., 1999; Rabins et al., 1999).
Conceptual frameworks do not differ in essence
with Lawton’s model of HRQL in dementia
(Lawton, 1994), although they limit the number
of domains. Different perspectives on HRQL
abound and are manifest in the variety of domains
represented in the different scales. For example,
the measurement of HRQL using the ADRQL
will widely differ to the one using the CDQLP
since they have very few domains in common.
Instruments also differ in their breadth of the
assessment and whether subjective experience of
the person with dementia is assessed or proxy
measures (observational or not) are used instead.
While self-reported measures are more appropriate
for measuring the patient’s own experience, in
severe stages, the use of instruments based on proxy
ratings is inevitable. Further, we found that there
is no single protocol for assessing the different
domains across instruments. This limits cross-study
comparability.
Country of development and validation
Most dementia-specific HRQL measures were
developed in the USA and UK. A number of scales
have been validated in other countries such as
Spain and Japan (Suzuki et al., 2005, 2006; Matsui
et al., 2006), increasing the availability. The QoL-
AD has been validated in at least ten different
countries and the D-QoL has been validated in
at least five different countries in the Americas,
Europe, and Asia. This allows for cross-county
comparisons. However, the concept of HRQL may
vary across different cultures and culturally specific
scales may also be needed. Further, for validation
studies is the issue of the representativeness of
samples used in development and validations
studies. None of the 15 instruments have been
developed using a population-based sample raising
issues of generalizability.
Dementia severity
Decisions for scale selection will depend on the
dementia severity. Self-rated instruments would
be more appropriate for mild-moderate stages
and proxy and observer-rated instruments more
appropriate at more severe stages of the disease.
Most of the extant dementia-specific HRQL
measures are proxy rated. This is a consequence
of the idea that people with dementia are not
able to rate their own HRQL due to cognitive
impairment. However, there is a strong movement
in measurement of HRQL in dementia to obtain
self-reports from the individual with dementia
where possible given recent findings that suggest
that people with mild to moderate dementia are
aware and able to assess their HRQL (Brod et al.,
1999; Mozley et al., 1999; Selai et al., 2001a;
Logsdon et al., 2002; Ready et al., 2002; Smith et al.,
2005a; Trigg et al., 2007b). Proxy informants have
a different point of view on the patient’s HRQL
and tend to give lower rating than people with
dementia (Logsdon et al., 2002; Thorgrimsen et al.,
2003). Even with careful training of observers, it is
uncertain whether the observed behaviors represent
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the most important and relevant aspects of HRQL,
as these measures have been developed to assess
the subjective perceptions of QoL. However, it has
been shown that proxies are as good as patients
in detecting changes in HRQL over time (Sneeuw
et al., 1997). Studies suggest that these differences
in reporting can be explained by the disability
paradox, caregiver states such as depression or
burden and the lack of patient’s insight (Carr and
Higginson, 2001; Logsdon et al., 2002; Novella
et al., 2012), but also by methodological issues
such as precision bias or response bias (Smith
et al., 2005a). Obtaining information from both
sources (patients and caregivers) is important since
they reflect different and imperfect measurements
of “true” state and may be contrasted, providing
richer information. A different approach is assessing
HRQL using different instruments covering all
dementia severities (Edelman et al., 2005); however,
this method can be confusing since different
conceptual frameworks are assumed when using
different measures.
Purpose of assessment
Instruments may be used for clinical practice or
for research. For clinical practice, since the main
aim is to help the individual to continue living
in the optimal fashion, the optimal scale will
be the one that lets the persons with dementia
assess a personal perception of HRQL allowing
a more individualized and, therefore, effective
treatment plan. To date, there is only one scale
that allows this type of assessment, the QOLAS
(Selai et al., 2001a). This is a double edged sword
since a drawback of this measure in research is
that, for this same reason, scores of the different
participants or the same participant in different
stages might not reflect the same concept of HRQL
and, therefore, comparisons do not seem to be
completely pertinent. This raises the question of
whether people can learn to consider certain aspects
when assessing their HRQL and dismiss others.
This would be useful for improving HRQL in
dementia.
For cross-sectional studies, operationalization,
country of development/validation and data
collection method will guide the selection of the
scale. However, when it comes to longitudinal
designs, the use of proxy and observer-rated
scales seems more appropriate since severity of
dementia is likely to change over time. For
both longitudinal and randomized control trials,
responsiveness is an important factor. To date,
at least six instruments have proved to have
a certain degree of responsiveness or sensitivity
to change. These measures are the BASQID,
QoL-AD, ADRQL,QUALID, PES-AD+AES, and
DCM. (Black et al., 1999; Albert et al., 2001; Fossey
et al., 2002; Thorgrimsen et al., 2003; Martin-Cook
et al., 2005; Trigg et al., 2007b).
Psychometric properties
Almost every measure showed good evidence of
internal consistency, and most measures have at
least tested reliability in two different ways. All
self-rated instruments and one scale of each of the
other data collection methods showed at least some
good evidence of acceptability. These scales are
the D-QoL and BASQID for self-rated, DEMQOL
for both self and proxy rated, and QoL-D and
QUALIDEM for proxy-rated. Content validity
has been mostly reached by qualitative evidence
from pretesting with patients, expert opinion,
and literature review that items in the scale are
representative of the construct. In-depth qualitative
interviews with people with dementia and/or their
carers were conducted for the D-QoL, DEMQOL,
BASQID, ADRQL, QUALIDEM, and QoL-D in
order to generate the scale items. A special case is
the QOLAS, in which the items are tailored to each
respondent. Although two measures (Selai et al.,
2001a; Ready et al., 2002) claim to measure it,
criterion-related validity cannot be assessed due to
the lack of a gold standard with which to compare
it. Convergent validity has mainly been assessed
by means of correlations between the scales and
measures of dementia severity (Albert et al., 1996;
Salek et al., 1996; Brod et al., 1999; Rabins et al.,
1999; Weiner et al., 2000; Selai et al., 2001a; Ready
et al., 2002; Yamamoto-Mitani et al., 2002; Porzsolt
et al., 2004; Smith et al., 2005a; Ettema et al.,
2007; Trigg et al., 2007b), depression (Rabins et al.,
1999; Selai et al., 2001a; Logsdon et al., 2002;
Smith et al., 2005a; Ettema et al., 2007), activities
of daily living (Rabins et al., 1999; Weiner et al.,
2000; Selai et al., 2001a; Logsdon et al., 2002;
Terada et al., 2002; Yamamoto-Mitani et al., 2002;
Porzsolt et al., 2004; Smith et al., 2005a), behavioral
and psychological symptoms (Weiner et al., 2000;
Ettema et al., 2007), and other measures of QoL
(Fossey et al., 2002; Smith et al., 2005a; Trigg
et al., 2007b). Discriminant validity has not often
been assessed and usually includes associations with
gender, age, or caregiver characteristics.
Scoring
A profile score or subscales of nine out of 15
instruments can be obtained. Within these nine,
three (ADRQL, QLDJ, and BASQID) (Rabins
et al., 1999; Yamamoto-Mitani et al., 2002; Trigg
et al., 2007b) can also calculate a total HRQL score.
The possibility of calculating subscale scores is vital
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for the assessment of HRQL. First, because HRQL
is by definition a multidimensional concept and,
therefore, the scores should represent each domain.
Second, if HRQL is to be used in order to assess
treatment benefits, subscale scores may shape those
treatments.
Conclusion
There has been much development on the
measurement of dementia-specific HRQL in the
last two decades. This is perhaps due to the lack
of consensus on the concept of HRQL in dementia.
It is also a reflection of the importance of assessing
HRQL in this group of people (Karlawish et al.,
2000;Whitehouse, 2000;Moniz-Cook et al., 2008).
The fact that dementia may be expressed in many
different ways makes the concept of HRQL in
dementia even more complex. The suitability of the
scale depends on several factors; namely countries
(development/validation), dementia severity (mild,
moderate, or severe), data collection method
(patient, proxy, both, or observer rating), purpose
of the assessment (clinical practice, research),
conceptualization and operationalization (domains
and items), psychometric properties (validity and
reliability), and scoring (total scores vs. subscales).
Many studies do not specifically set out to measure
dementia-specific HRQL but do include related
items as part of their surveys that together may
function as a HRQL scale (e.g. items on depression,
social interaction, or enjoyment of activities). This
paper may also be useful for mapping HRQL
dimensions in such studies maximizing the value of
existing resources. In order to do so, item analyses
could determine the performance of frequently
used questions in dementia HRQL instruments.
These items could also be mapped onto already
existing conceptual frameworks. The items to be
used will depend on how severe the dementia is and
how the information was administered. However,
validity and reliability will have to be analyzed if
this is to be conducted. Future studies validating
each scale across samples (community vs. clinical),
populations, and cohorts are needed to be able to
generalize results.
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